Mumbai headquartered Elder Pharmaceuticals announced that the company has inked a pact with Japanese drug maker Daiwa Pharmaceuticals.

According to sources, under the proposed agreement, the company will make and sell some of the products of Daiwa Pharmaceuticals in the country.

The sources also revealed that Daiwa Pharmaceuticals proposes to roll out its new product ‘IMBRAN’, a nutritional supplement for immunity enhancement, in the Indian market.

Daiwa Pharmaceuticals specializes in health supplements and functional foods and its products are accepted in more than 42 countries, it added.

Japanese drug maker (Daiwa Pharmaceuticals) engages in health supplements and functional foods. It sells its products in more than 40 countries.

In addition to making its own pharmaceutical products, Elder Pharmaceuticals also sells and manufactures products through license pacts with international pharmaceutical majors like Daiwa.

At present, the company has three manufacturing units in Maharashtra in Nerul, Pawane and Patalganga.